Posts by Serguei Melnitchouk, MD, MPH
Review: Optimal Anticoagulation After Bioprosthetic Valve Replacement
Massachusetts General Hospital researchers review medical society guidelines about anticoagulation and antiplatelet therapy after bioprosthetic aortic and mitral valve replacement—and propose their own strategies.
Prior Sternotomy Linked to Worse Survival After Cardiac Transplantation
A history of sternotomy is a risk factor for worse survival after cardiac transplantation, cardiac surgeons at Massachusetts General Hospital determined after reviewing nationwide data.
Study Explores Novel Transcatheter Mitral Valve Replacement
The APOLLO Trial is investigating minimally invasive mitral valve replacement as an alternative to open heart surgery for patients with severe mitral valve regurgitation. Massachusetts General Hospital's team is leading efforts to explore the innovative procedure's safety and effectiveness.
First Minimally-invasive Transcatheter Mitral Valve Replacement in New England Performed at Mass General
Physicians at Massachusetts General Hospital recently became the first team in New England to perform a transcatheter mitral valve replacement in a non-calcified mitral valve.
Left Ventricular-Mitral Valve Ring Ratio May Predict Recurrent Mitral Regurgitation
Researchers found that a mismatch in left ventricular and mitral valve ring size can predict whether a patient is at a higher risk of recurrent mitral regurgitation after mitral valve repair.
Paradigm Shift in Mitral Valve Repair Management and Treatment
Chronic severe MR patients are without intervention until symptoms appear. Advances in minimally invasive procedures lead to successful earlier intervention.
Serguei Melnitchouk, MD, MPH, is a board-certified cardiac surgeon at Massachusetts General Hospital specializing in coronary bypass and valve surgery with a focus on minimally invasive mitral valve surgery and transcatheter aortic valve replacement (TAVR). Dr. Melnitchouk is also involved with the Lung Transplant and ECMO programs at the Mass General Transplant Center.
Dr. Melnitchouk received his medical degree at Ruprecht-Karls-University in Heidelberg, Germany and his Master's of Public Health at the Harvard School of Public Health. Dr. Melnitchouk completed his general surgery residency at Brigham and Women's Hospital and Mass General and a cardiothoracic surgery residency at New York Presbyterian Hospital/Columbia University Medical Center. He has also completed an additional fellowship training in the minimally invasive mitral valve repair at the Leipzig Heart Center, Germany.
Dr. Melnitchouk is the quality director for the Division of Cardiac Surgery. He leads initiatives in identifying ways to measure the division's quality of care while improving patient care and experience. He is assistant professor of surgery at Harvard Medical School.